CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms

/PRNewswire/ -- A randomised, double-blind, placebo-controlled trial (RECOVERY STUDY) conducted by The Chinese University of Hong Kong (CUHK)'s Faculty of...

Related Keywords

University Of Hong Kong ,Hong Kong General ,Hong Kong , ,Centre For Gut Microbiota Research ,Cu Medicine Croucher Professor Of Medical Sciences ,Lancet Group ,Chinese University Of Hong Kong ,Research Fund ,Chinese University ,Microbiotai Center ,Lancet Infectious Disease ,Croucher Professor ,Medical Sciences ,Gut Microbiota Research ,Medical Research Fund ,Hong Kong Special Administrative ,The Faculty Of Medicine Chinese University Hong Kong ,Medical Pharmaceuticals ,Pharmaceuticals ,Health Care Amp Hospitals ,Education ,Infection Control ,Clinical Trials Amp Medical Discoveries ,